Linked from

The 13 pages that link to Monoamine oxidase inhibitor, each with the reason it gives.

• Selective serotonin reuptake inhibitorCompared with: MAOIs increase monoamine availability through a different mechanism and have distinctive interaction precautions.

• Serotonin syndromeRelated: Combining them with certain serotonergic drugs can sharply increase serotonin activity.

• AntidepressantBroader topic: MAOIs change neurotransmitter breakdown rather than blocking reuptake and require attention to interactions.

• BupropionCompared with: Combining an MAOI with bupropion is contraindicated because of potentially dangerous interactions.

• Serotonin-norepinephrine reuptake inhibitorCompared with: This class raises monoamine availability by slowing breakdown, not by blocking reuptake.

• Tricyclic antidepressantCompared with: MAOIs increase monoamine signaling through a different mechanism and carry distinct interaction risks.

• FluoxetineCompared with: Combining this class with fluoxetine can cause dangerous serotonin toxicity and requires careful timing.

• Monoamine oxidaseBroader topic: These agents raise levels of monoamines by slowing their enzymatic breakdown.

• BuspironeCompared with: Combining buspirone with an MAOI is contraindicated because of serious interaction risks.

• TyramineRelated: These drugs can prevent tyramine breakdown and make dietary exposure more consequential.

• ImipramineCompared with: This older antidepressant class has different interaction hazards and is not combined casually with imipramine.

• PseudoephedrineRelated: Combining one with pseudoephedrine can sharply intensify blood-pressure and cardiovascular effects.

• PethidineCompared with: Combining pethidine with these drugs can provoke severe, potentially fatal reactions.